Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"The brilliance (I claim) of the AVXL trial plan w/PDD and RS is it should show the MOA (thx XENA) demonstrated in these should show/demonstrate FUNCTIONAL (sleep, spasm, movement range, etc) results which are more easily and accurately measured early on a time line.
The end points will demonstrate this plan and (IMO) RWE/RWD will support along w/caregiver reports and anecdotes. So what you say, We already knew that.
So, before the dementia curtain starts to come down on AD patients valuable time is lost, we have to get that back while we try to develop biomarkers that really tell us something. IMO, that is what is going on right now while we wait for the trials to start.
Since AD stage cannot yet be measured w/confidence (functional) until it is too late the PDD/RS trials are vicariously on the point while the AD debate of function vs cognition rages for stage 1,2. The early choice of these two CNS disease trials as indicators (along w/other choices we do not know about) are evidence of a good plan."
= THE BEST SCENARIO. THANKS!
Isn't "We already knew that" by Dr. M? : )
Betya!
That is what Dr. Harald Hampel thinks. Bold letters by me.
Harald Hampel
November 13 at 11:23 PM ·
The interview on my invited emerging topic presentation of the promising Anavex 2-73 clinical trial data and Alzheimer Precision Medicine (APM) at the with Neurology Live during the AAIC 2018 in Chicago.
https://www.facebook.com/harald.hampel.7
Yea I’ve seen it a couple of times before.
From Dr. Harald Hampel's Face Book
https://www.facebook.com/harald.hampel.7
He uploaded old videos from AAIC 2018 but note he said "promising Anavex " - bold by me.
Harald Hampel
November 13 at 11:42 PM
The video on my invited emerging topic presentation of the promising Anavex 2-73 clinical trial data and Alzheimer Precision Medicine (APM) at the with Neurology Live during the AAIC 2018 in Chicago.
Harald Hampel
November 13 at 11:23 PM ·
The interview on my invited emerging topic presentation of the promising Anavex 2-73 clinical trial data and Alzheimer Precision Medicine (APM) at the with Neurology Live during the AAIC 2018 in Chicago.
GLTA
Are you buying I guess? It’s a chance to overachieve.
You are right. I’m just sitting.
I just can not sell when pps jumps up thinking it will continue going up on. Lol
Intersting they mention yet-to-be-approved A273 in Treatments section.
Thank you for your reply and long explanation.
It’s true that when I think back my 3 year of investment in Anavex I get marbled at a fact that we have not had negative scientific news/contradictions except one by AF about 3 years ago.
You are a very prudent person. May I ask you how you found Anavex’s science?
You probably are right. However I do know that stocks do not move as you expected and I believe something unexpected will happen before the end of 2Q 2019.
Actually this site says the report date for Park West's 500k shares is on 11-14-2018 which I did not see earlier.
Scroll down and go to page 3
https://whalewisdom.com/stock/avxl?selected_quarter=70
Still diggin? Sell,sell,sell. Lol
I’m getting tired of pps predictions.
I just want pps over 3.0, brothers.
Sorry, you keep on using numbers from 2Q.
https://whalewisdom.com/stock/avxl?selected_quarter=70
Scroll all the way down to see Park West and Vangard
I think all numbers in your post are of 2Q.
https://whalewisdom.com/stock/avxl
Wasn't it 15% at the end of 2Q?
https://whalewisdom.com/stock/avxl
Will never be much of a market for Anavex 273 in the Netherlands, when snuffing people with early stage dementia is so much more cost-efficient.
It is on topic. :)
Hope so. Tutes holding AVXL 2Q 2018- Not much change.
Looking for 13F for 3Q.
https://whalewisdom.com/stock/avxl
2.30 WTF
Good one. Me think someone just got retired.
Some volume here with inching up and asking @0.0017.
More sells than buys but they appear to be old orders sitting for months taken out. That’s good.
Who’s buying? Is it MM’s doing their job,es1?
9000 US citizens developing AD every week- just unbelievable!
That number is close to 1500 every two weeks in Australia for their population.
I was going to the point that US government should put efforts/funds x10 than Australia.
AVXL
AMEN! My thoughts are same.
No one knows sudden drops of stocks; same for breakouts.
I recently learned that the population of Australia is relatively small: 25 million VS 325 mil USA.
And their 1500 citizens get dementia every week (or two?)?
Is that mean more than 15000 in USA get dementia every week?
That is mind boggling to say the least.
You'd know that I knew. I pretended that I did not know; I was soft today. Lol
You have been digging hard for long time.
Do you still have a plan to invest in AVXL?
Which data comes first, PDD or PD?
That is the question.
I'm happy that we have two chances in 2019, maybe three. : )
AVXL
What is your interest in AVXL, just wonder?
Sorry, anyone knows what happened to.........
TPIV? MB is gone in iHub.
I googled it to find all old news.
What doesn’t iHub leave MB even after the ticker changed?
TIA
Lol, like it.
I do hope to have a new floor around $6 for whatever reasons. haha
Sick and tired of being at this bottom around 2.4
You wanna bet?
Janssen Biotech Inc made a deal for a ph1/2 drug yesterday:
The compound is currently in an ongoing Phase 1/2 clinical trials in Korea. Interim results showed that Lazertinib exhibited robust disease activity..........
Under the terms of the agreement, Yuhan will receive an upfront payment of US$50 million and is eligible to receive up to US$1.205 billion in potential development and commercial milestone payments, along with tiered double-digit royalties on future net sales.
I get that cabal can control SP but how they control volume?
Financial should be coming sooooooon.
Kudos to Aussie government and thank you for sharing!
AVXL
I do agree with you. however I've seen small bio companies move up for some reasons we can not without news. That is what I hope for.
Good news this am
Thank you for your contribution.
Is this it?
250k volume in the first 30 minutes.